SC1-PM-06-2016
SC1-PM-06-2016
6 projects · €46,795,043 total EU contribution (project-level) · 44 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€46,795,043
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (9)
- France (7)
- Netherlands (5)
- SE (5)
- Germany (4)
- BE (2)
- CH (2)
- DK (2)
- TR (2)
- AT (1)
- AU (1)
- BG (1)
- TJ (1)
- US (1)
- XK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CEA2 projects · FR
- EXPRES2ION2 projects · DK
- GRL2 projects · UK
- IMAXIO2 projects · FR
- IRD2 projects · FR
- LSHTM2 projects · UK
- NOVAVAX AB2 projects · SE
- OSIVAX2 projects · FR
- SSI2 projects · DK
- UOXF2 projects · UK
- Leiden University Medical Center1 projects · NL
- PEI1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Fast track development of a Zika vaccine based on measles vector ZIKAVAX · 732432 | H2020 | €4,918,138 | €673,969 | Details |
Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria MultiViVax · 733073 | H2020 | €5,058,974 | €44,842 | Details |
Developing a Chlamydia Trachomatis vaccine TracVac · 733373 | H2020 | €6,674,498 | €1,012,656 | Details |
Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine RABYD-VAX · 733176 | H2020 | €4,113,385 | €649,705 | Details |
Optimizing a deployable high efficacy malaria vaccine OptiMalVax · 733273 | H2020 | €20,050,441 | €437,500 | Details |
Crimean-Congo Haemorrhagic Fever Vaccine CCHFVaccine · 732732 | H2020 | €5,979,607 | €2,550,250 | Details |